|Description||CD1530 is a potent and selective retinoic acid receptor(RAR) agonist with Ki values of 150, 1500 and 2750 nM for RARγ, RARβ and RARα receptors respectively. It was also a potent CYP26A1 inhibitor as ketoconazole with an IC50 value of 530 nM. It inhibited excessive ROS production in tongue epithelial cells in vitro. It demonstrates transcriptional activity at RARγ with an AC50 value of 1.8 nM. It has been shown to preserve human tendon stem cell characteristics, promote repair of injured skeletal muscle, and in combination with bexarotene to inhibit oral carcinogenesis.|
|Synonyms||4-(6-Hydroxy-7-tricyclo[184.108.40.206,7]dec-1-yl-2-naphthalenyl)benzoicacid; CD1530; CD 1530; CD-1530.4-(7-((3R,5R,7R)-adamantan-1-yl)-6-hydroxynaphthalen-2-yl)benzoic acid;4-[7-(1-Adamantyl)-6-hydroxynaphthalen-2-yl]benzoic acid|
|Solubility||Soluble to 50 mM in 1eq. NaOH,DMSO: soluble20 mg/mL, clear|
|Application||CD1530 has been shown to preserve human tendon stem cell characteristics, promote repair of injured skeletal muscle, and in combination with bexarotene to inhibit oral carcinogenesis.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Boiling Point||610.7±55.0 °C | Condition: Press: 760 Torr|
|Density||1.290±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
CD1530 is a potent and selective retinoic acid receptor(RAR) agonist with Ki values of 150, 1500 and 2750 nM for RARγ, RARβ and RARα receptors respectively. It ...
Acitretin is a second generation retinoid used for psoriasis.
LY 2955303 hydrochloride is a potent and selective retinoic acid receptor gamma (RARγ) antagonist (Ki values >1700 nM, >2980 nM, and 1.1 nM for RARα, RARβ, and ...
AGN 196996 is a potent and selective antagonist of RARα. It has been reported to selectively bind to RARs (retinoic acid receptors) for RARα, RARβ and RARγ. It...
NRX-204647 is a Retinoic acid receptor gamma-selective inverse agonist.
TTNPB potently and selectively activates retinoic acid receptors (EC50s = 21, 4, and 2.4 nM for RARα, RARβ, and RARγ, respectively). And it does not act on reti...
BMS 493 is a pan-retinoic acid receptor (pan-RAR) inverse agonist that enhances interaction of nuclear corepressor (NCoR) and RARs.
BMS 753 is a RARα-selective agonist (Ki = 2 nM) that modulates the ATRA-inducible cytochrome P450 26A1 (CYP26A1).